| NCT Number | NCT04494295 |
| Lead Sponsor | Integra LifeSciences Corporation
Collaborators: Icahn School of Medicine at Mount Sinai, Oculus Imaging LLC |
| Conditions | Supratentorial Hemorrhage |
| Enrollment | 500 participants |
| Start Date | 2020-10-23 |
| Primary Completion | 2028-10-15 (estimated) |
| Study Completion | 2029-10-15 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-06 |